Serous ovarian, fallopian tube and primary peritoneal cancers: A common disease or separate entities - A systematic review

Gynecologic Oncology

Volumn 136, Issue 3, 2015, Pages 571-581

  Sørensen, Rie D ^a   Schnack, Tine H ^b   Karlsen, Mona A ^c   Høgdall, Claus K ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epithelial ovarian cancer; Fallopian tube cancer; Molecular biology; Primary peritoneal cancer; Risk factors; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

AGE; BODY MASS; BREAST FEEDING; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENICITY; CASE CONTROL STUDY; CONTROL GROUP; CYTOREDUCTIVE SURGERY; FAMILY HISTORY; FEMALE INFERTILITY; GENE MUTATION; HETEROZYGOSITY LOSS; HORMONAL CONTRACEPTION; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MEDLINE; MENARCHE; MENOPAUSE; MOLECULAR BIOLOGY; OBESITY; OVARY CARCINOMA; PARITY; PERITONEUM CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; UTERINE TUBE CARCINOMA; UTERINE TUBE LIGATION; FALLOPIAN TUBE NEOPLASMS; FEMALE; HEALTH; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

FALLOPIAN TUBE NEOPLASMS; FEMALE; GLOBAL HEALTH; HUMANS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84924227326     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.01.534     Document Type: Review

References (63)

1. C.K. Høgdall LT, and M.L.S. Nielsen Årsrapport - Dansk Gynækologisk Cancer Database Landsdækkende klinisk database for kræft i æggestokke, livmoder og livmoderhals December 2012 Dansk Gynækologisk Cancer Gruppe (DGCG)
2. M.T. Goodman, and Y.B. Shvetsov Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004 Cancer Epidemiol. Biomarkers Prev. 18 1 2009 132 139
3. J.S. Berek, C. Crum, and M. Friedlander Cancer of the ovary, fallopian tube, and peritoneum Int. J. Gynecol. Obstet. 119 2012 S118 S129
4. S.J. Jordan, A.C. Green, D.C. Whiteman, S.P. Moore, C.J. Bain, and D.M. Gertig Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis Int. J. Cancer 122 7 2008 1598 1603
5. G. Chene, J. Dauplat, N. Radosevic-Robin, A. Cayre, and F. Penault-Llorca Tu-be or not tu-be: that is the question... about serous ovarian carcinogenesis Crit. Rev. Oncol. Hematol. 88 1 2013 134 143
6. J.D. Bloss, S.Y. Liao, R.E. Buller, A. Manetta, M.L. Berman, and S. McMeekin Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary Gynecol. Oncol. 50 3 1993 347 351
7. T.H. Schnack, R.D. Sorensen, L. Nedergaard, and C. Hogdall Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology - a prospective comparative study Gynecol. Oncol. 135 2 2014 278 284
8. G.H. Eltabbakh, M.S. Piver, N. Natarajan, and C.J. Mettlin Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer Obstet. Gynecol. 91 2 1998 254 259
9. D.J. Grant, P.G. Moorman, L. Akushevich, R.T. Palmieri, R.C. Bentley, and J.M. Schildkraut Primary peritoneal and ovarian cancers: an epidemiological comparative analysis Cancer Causes Control 21 7 2010 991 998
10. R. Halperin, S. Zehavi, R. Langer, E. Hadas, I. Bukovsky, and D. Schneider Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer Int. J. Gynecol. Cancer 11 5 2001 403 408
11. G. Barda, J. Menczer, A. Chetrit, F. Lubin, D. Beck, and B. Piura Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study Am. J. Obstet. Gynecol. 190 4 2004 1039 1045
12. A. Ayhan, C. Taskiran, N. Yigit-Celik, G. Bozdag, M. Gultekin, and A. Usubutun Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer? Int. J. Gynecol. Cancer 16 2 2006 484 489
13. A. Riska, R. Sund, E. Pukkala, M. Gissler, and A. Leminen Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975 - 2004 Int. J. Cancer 120 8 2007 1351 1354
14. M.S. Dunn, K.J. Manahan, and J.P. Geisler Primary carcinoma of the fallopian tube and epithelial ovarian carcinoma: a case-control analysis J. Reprod. Med. 53 9 2008 691 694
15. D. Vicus, A. Finch, B. Rosen, I. Fan, L. Bradley, and I. Cass Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation Gynecol. Oncol. 118 2 2010 155 159
16. J.D. Bloss, M.F. Brady, S.Y. Liao, T. Rocereto, E.E. Partridge, and D.L. Clarke-Pearson Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma - a Gynecologic Oncology Group Study Gynecol. Oncol. 89 1 2003 148 154
17. I. Usach, K. Blansit, L.M. Chen, S. Ueda, R. Brooks, and D.S. Kapp Survival differences of serous tubal, ovarian, peritoneal and uterine carcinomas Am. J. Obstet. Gynecol. 2014 Aug 18. [Epub ahead of print]
18. G. Dubernard, P. Morice, A. Rey, S. Camatte, V. Fourchotte, and A. Thoury Prognosis of stage III or IV primary peritoneal serous papillary carcinoma Eur. J. Surg. Oncol. 30 9 2004 976 981
19. I. Khalifeh, A.R. Munkarah, F. Lonardo, J.M. Malone, R. Morris, and W.D. Lawrence Expression of Cox-2, CD34, Bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma Int. J. Gynecol. Pathol. 23 2 2004 162 169
20. S.L. Wethington, T.J. Herzog, V.E. Seshan, N. Bansal, P.B. Schiff, and W.M. Burke Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer Cancer 113 12 2008 3298 3306
21. K.N. Moore, K.M. Moxley, A.N. Fader, A.E. Axtell, R.P. Rocconi, and L.N. Abaid Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary Gynecol. Oncol. 107 3 2007 398 403
22. I. Cass, R.L. Baldwin, E. Fasylova, A.L. Fields, H.P. Klinger, and C.D. Runowicz Allelotype of papillary serous peritoneal carcinomas Gynecol. Oncol. 82 1 2001 69 76
23. J.C. Dalrymple, P. Bannatyne, P. Russell, H.J. Solomon, M.H. Tattersall, and K. Atkinson Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases Cancer 64 1 1989 110 115
24. M.A. Killackey, and A.R. Davis Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma Gynecol. Oncol. 51 2 1993 171 174
25. J.O. Schorge, Y.B. Miller, L.J. Qi, M.G. Muto, W.R. Welch, and R.S. Berkowitz Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum Gynecol. Oncol. 76 3 2000 369 372
26. E.L. Eisenhauer, Y. Sonoda, D.A. Levine, N.R. Abu-Rustum, M.L. Gemignani, and P.J. Sabbatini Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma Am. J. Obstet. Gynecol. 198 2 2008 213.e1 213.e7
27. L.D. Kowalski, A.I. Kanbour, F.V. Price, S.D. Finkelstein, W.A. Christopherson, and J.C. Seski A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma Cancer 79 8 1997 1587 1594
28. R. Halperin, S. Zehavi, E. Hadas, L. Habler, I. Bukovsky, and D. Schneider Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma Int. J. Gynecol. Pathol. 20 4 2001 341 345
29. L.M. Chen, S.D. Yamada, Y.S. Fu, R.L. Baldwin, and B.Y. Karlan Molecular similarities between primary peritoneal and primary ovarian carcinomas Int. J. Gynecol. Cancer 13 6 2003 749 755
30. L.W. Huang, A.P. Garrett, J.O. Schorge, M.G. Muto, D.A. Bell, and W.R. Welch Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum Am. J. Clin. Pathol. 114 1 2000 93 99
31. L.W. Huang, A.P. Garrett, M.G. Muto, C.V. Colitti, D.A. Bell, and W.R. Welch Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum Hum. Pathol. 31 3 2000 367 373
32. A.P. Garrett, S.W. Ng, M.G. Muto, W.R. Welch, D.A. Bell, and R.S. Berkowitz ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum Gynecol. Oncol. 77 1 2000 105 111
33. P.M. Diniz, J.P. Carvalho, E.C. Baracat, and F.M. Carvalho Fallopian tube origin of supposed ovarian high-grade serous carcinomas Clinics (Sao Paulo) 66 1 2011 73 76
34. D.W. Kindelberger, Y. Lee, A. Miron, M.S. Hirsch, C. Feltmate, and F. Medeiros Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am. J. Surg. Pathol. 31 2 2007 161 169
35. C.G. Przybycin, R.J. Kurman, B.M. Ronnett, M. Shih Ie, and R. Vang Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am. J. Surg. Pathol. 34 10 2010 1407 1416
36. S. Tang, K. Onuma, P. Deb, E. Wang, A. Lytwyn, and M. Sur Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases Int. J. Gynecol. Pathol. 31 2 2012 103 110
37. T. Riman, P.W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, and C.M. Magnusson Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study Am. J. Epidemiol. 156 4 2002 363 373
38. M.A. Merritt, M. De Pari, A.F. Vitonis, L.J. Titus, D.W. Cramer, and K.L. Terry Reproductive characteristics in relation to ovarian cancer risk by histologic pathways Hum. Reprod. 28 5 2013 1406 1417
39. M. Baekelandt, A. Jorunn Nesbakken, G.B. Kristensen, C.G. Trope, and V.M. Abeler Carcinoma of the fallopian tube Cancer 89 10 2000 2076 2084
40. A. Gadducci, F. Landoni, E. Sartori, T. Maggino, P. Zola, and A. Gabriele Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study Gynecol. Oncol. 81 2 2001 150 159
41. I. Alvarado-Cabrero, S. Stolnicu, T. Kiyokawa, K. Yamada, T. Nikaido, and H. Santiago-Payan Carcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors Ann. Diagn. Pathol. 17 2 2013 159 164
42. Y.J. Koo, K.S. Im, Y.S. Kwon, I.H. Lee, T.J. Kim, and K.T. Lim Primary fallopian tube carcinoma: a clinicopathological analysis of a rare entity Int. J. Clin. Oncol. 16 1 2011 45 49
43. M.F. Benoit, and E.V. Hannigan A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers Int. J. Gynecol. Cancer 16 1 2006 29 35
44. M.F. Fathalla Incessant ovulation - A Factor in Ovarian Neoplasia? The Lancet. 298 7716 1971 163
45. H.A. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone J. Natl. Cancer Inst. 90 23 1998 1774 1786
46. C.M. Olsen, C.M. Nagle, D.C. Whiteman, D.M. Purdie, A.C. Green, and P.M. Webb Body size and risk of epithelial ovarian and related cancers: a population-based case-control study Int. J. Cancer 123 2 2008 450 456
47. M. Luyckx, E. Leblanc, T. Filleron, P. Morice, E. Darai, and J.M. Classe Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study Int. J. Gynecol. Cancer 22 8 2012 1337 1343
48. E.V. Hogdall, L. Christensen, C.K. Hogdall, J. Blaakaer, S. Gayther, and I.J. Jacobs Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study Oncol. Rep. 18 5 2007 1051 1059
49. D. Zhao, F. Zhang, W. Zhang, J. He, Y. Zhao, and J. Sun Prognostic role of hormone receptors in ovarian cancer: a systematic review and meta-analysis Int. J. Gynecol. Cancer 23 1 2013 25 33
50. E.V. Hogdall, L. Christensen, S.K. Kjaer, J. Blaakaer, J.E. Bock, and E. Glud Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study Cancer 98 1 2003 66 73
51. M.C. Heeran, C.K. Hogdall, S.K. Kjaer, L. Christensen, A. Jensen, and J. Blaakaer Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study Acta Pathol. Microbiol. Immunol. Scand. 121 12 2013 1177 1186
52. M.Q. Lacy, L.C. Hartmann, G.L. Keeney, S.C. Cha, H.S. Wieand, and K.C. Podratz c-erbB-2 and p53 expression in fallopian tube carcinoma Cancer 75 12 1995 2891 2896
53. M.E. Nowee, J.C. Dorsman, J.M. Piek, V.M. Kosma, K. Hamalainen, and R.H. Verheijen HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study Histopathology 51 5 2007 666 673
54. M. Stuhlinger, A.C. Rosen, K. Dobianer, C. Hruza, H. Helmer, and M. Kein HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for Fallopian Tube Carcinoma Oncology 52 5 1995 397 399
55. U.M. Moll, F. Valea, and J. Chumas Role of p53 alteration in primary peritoneal carcinoma Int. J. Gynecol. Pathol. 16 2 1997 156 162
56. C.H. Mok, S.W. Tsao, R.C. Knapp, P.M. Fishbaugh, and C.C. Lau Unifocal origin of advanced human epithelial ovarian cancers Cancer Res. 52 18 1992 5119 5122
57. S.W. Tsao, C.H. Mok, R.C. Knapp, K. Oike, M.G. Muto, and W.R. Welch Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas Gynecol. Oncol. 48 1 1993 5 10
58. D.C. Marchion, Y. Xiong, H.S. Chon, E. Al Sawah, N. Bou Zgheib, and I.J. Ramirez Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer Am. J. Obstet. Gynecol. 209 6 2013 576.e1 576.e16
59. L. Khalique, A. Ayhan, J.C. Whittaker, N. Singh, I.J. Jacobs, and S.A. Gayther The clonal evolution of metastases from primary serous epithelial ovarian cancers Int. J. Cancer 124 7 2009 1579 1586
60. J.W. Carlson, A. Miron, E.A. Jarboe, M.M. Parast, M.S. Hirsch, and Y. Lee Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 26 25 2008 4160 4165
61. L.C. Horn, S. Kafkova, K. Leonhardt, C. Kellner, and J. Einenkel Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas Int. J. Gynecol. Pathol. 32 4 2013 339 344
62. J.D. Seidman, P. Zhao, and A. Yemelyanova "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer Gynecol. Oncol. 120 3 2011 470 473
63. F.F. Gao, R. Bhargava, H. Yang, Z. Li, and C. Zhao Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin? Hum. Pathol. 44 8 2013 1534 1543